C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2011
08/04/2011	US20110186432 Buffers for electrophoresis and use thereof
08/04/2011	CA2851105A1 Polynucleotide encoding acyl-coa synthetase homolog and use thereof
08/04/2011	CA2818599A1 Polynucleotide and polypeptide sequences associated with herbicide tolerance
08/04/2011	CA2803401A1 Methods and kits used in the detection of fungus
08/04/2011	CA2788726A1 Oligopeptidic compounds and uses thereof
08/04/2011	CA2788635A1 Enhanced efficiency of induced pluripotent stem cell generation
08/04/2011	CA2788198A1 Hppd-inhibitor herbicide tolerance
08/04/2011	CA2788080A1 Nucleic acid construct comprising pyripyropene biosynthetic gene cluster and marker gene
08/04/2011	CA2788058A1 Method for producing pyripyropene
08/04/2011	CA2788045A1 Microorganism production of high-valve chemical products, and related compositions, methods and systems
08/04/2011	CA2788003A1 Genes encoding proteins able to enhance heat resistance of plants and microorganisms and uses thereof
08/04/2011	CA2787832A1 Polynucleotide encoding acyl-coa synthetase homolog and method and use thereof
08/04/2011	CA2787829A1 Method for producing pyripyropene derivatives by the enzymatic method
08/04/2011	CA2787827A1 A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
08/04/2011	CA2787787A1 Transformation plasmid
08/04/2011	CA2787590A1 Transformation plasmid
08/04/2011	CA2787314A1 Microorganisms and methods for the biosynthesis of p-toluate and terephthalate
08/04/2011	CA2787285A1 Methods and compositions using fgf23 fusion polypeptides
08/04/2011	CA2787070A1 Cd127 binding proteins
08/04/2011	CA2786333A1 Vaccinia virus mutants containing the major genomic deletions of mva
08/03/2011	EP2351859A1 Methods and agents for screening for compounds capable of modulating gene expression
08/03/2011	EP2351855A1 RNA aptamers and methods for identifying the same
08/03/2011	EP2351854A1 Coding sequences of the human BRCA1 gene
08/03/2011	EP2351853A1 Method and devices for multiplexing amplification reactions
08/03/2011	EP2351852A1 RNA interference mediating small RNA molecules
08/03/2011	EP2351851A1 Method for measuring cytokeratin-19 mrna
08/03/2011	EP2351850A1 Method for determining presence or absence of abnormal cell
08/03/2011	EP2351848A1 Method for producing l-amino acid
08/03/2011	EP2351844A1 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells
08/03/2011	EP2351843A2 Rabies virus vector systems and compositions and methods thereof
08/03/2011	EP2351842A1 Method for isolation of soluble polypeptides
08/03/2011	EP2351841A1 Method for isolation of soluble polypeptides
08/03/2011	EP2351840A1 Polypeptides involved in immune response
08/03/2011	EP2351839A2 Antisense antibacterial method and compound
08/03/2011	EP2351838A1 Crosslinking agonistic antibodies
08/03/2011	EP2351837A1 Method for designing mutant enzyme, method for preparing mutant enzyme, and mutant enzyme
08/03/2011	EP2351836A1 Double-stranded oligonucleotides
08/03/2011	EP2351834A2 Production of biologically active proteins
08/03/2011	EP2351827A1 Culture medium for cell growth and transfection
08/03/2011	EP2351777A1 Anti-muc1 antibody
08/03/2011	EP2351775A1 Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof
08/03/2011	EP2351769A2 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
08/03/2011	EP2351767A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/03/2011	EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use
08/03/2011	EP2351585A1 Anti-hepatitis c virus composition
08/03/2011	EP2351483A1 Prevention and treatment of blood coagulation-related diseases
08/03/2011	EP2350656A1 Methods and kits to identify invasive glioblastoma
08/03/2011	EP2350617A2 A method and apparatus for analysis of a particle
08/03/2011	EP2350317A2 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
08/03/2011	EP2350316A1 Methods and uses involving genetic aberrations of nav3 and aberrant expression of multiple genes
08/03/2011	EP2350302A1 Rapid and safe technique for performing pcr amplifications
08/03/2011	EP2350297A2 Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo
08/03/2011	EP2350296A1 Branched cationic lipids for nucleic acids delivery system
08/03/2011	EP2350295A1 Lcmv-gp-vsv-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
08/03/2011	EP2350294A2 Models of thrombotic thrombocytopenic purpura and methods of use thereof
08/03/2011	EP2350293A1 Them5- modified models of non-alcoholic fatty liver disease
08/03/2011	EP2350292A1 Insect-derived promoters for foreign proteins expression in insect cells
08/03/2011	EP2350291A1 Vegetabile material, plants and a method of producing a plant having altered lignin properties
08/03/2011	EP2350290A1 Method for producing male sterile plants
08/03/2011	EP2350289A1 Plants with increased yield (nue)
08/03/2011	EP2350288A1 Methods and means to modify fiber strength in fiber-producing plants
08/03/2011	EP2350287A2 A method for producing a transgenic cell with increased gamma-aminobutyric acid (gaba) content
08/03/2011	EP2350286A2 Recombinant nell protein production
08/03/2011	EP2350285A2 Protein expression
08/03/2011	EP2350284A1 Hybrid-type histidine kinase gene isolated from indica rice ir64
08/03/2011	EP2350283A2 Compounds and methods for the treatment of inflammatory diseases of the cns
08/03/2011	EP2350282A1 Increased expression of specific antigens
08/03/2011	EP2350281A1 Multiple exon skipping compositions for dmd
08/03/2011	EP2350280A1 Immunosuppression compound and treatment method
08/03/2011	EP2350279A2 Methods for treating eye disorders
08/03/2011	EP2350278A2 Means for inhibiting the expression of orc-1
08/03/2011	EP2350277A1 Methods and compositions for prevention or treatment of rsv infection using modified duplex rna molecules
08/03/2011	EP2350276A1 Syngr4 for target genes of cancer therapy and diagnosis
08/03/2011	EP2350273A2 Compositions of engineered human arginases and methods for treating cancer
08/03/2011	EP2350272A1 Hosts and fermentation processes for cellulase production
08/03/2011	EP2350270A2 Human ebola virus species and compositions and methods thereof
08/03/2011	EP2350269A1 Simian adenoviruses sadv-43, -45,-48,-49, and -50 and uses thereof
08/03/2011	EP2350268A1 Method for the production of adenoviral vectors
08/03/2011	EP2350267A1 Production of products of pharmaceutical interest in plant cell cultures
08/03/2011	EP2350131A2 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
08/03/2011	EP2350129A2 Compositions of pd-1 antagonists and methods of use
08/03/2011	EP2350125A1 Hla-g polypeptides and pharmaceutical uses thereof
08/03/2011	EP2350123A1 Novel tools for the production of glycosylated proteins in host cells
08/03/2011	EP2350122A1 Methods of enhancing translocation of charged analytes through transmembrane protein pores
08/03/2011	EP2349210A2 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics
08/03/2011	EP2348827A1 Immunocompromised ungulates
08/03/2011	EP2118292B1 Papillomavirus e2 polypeptide used for vaccination
08/03/2011	EP2115130B1 Ketoreductases and uses thereof
08/03/2011	EP2102337B1 A microorganism of corynebacterium genus having enhanced l-lysine productivity and a method of producing l-lysine using the same
08/03/2011	EP1970446B1 Nuclear reprogramming factor
08/03/2011	EP1954809B1 Methods for indentifying markers for early-stage human cancer, cancer progression and recurrence
08/03/2011	EP1924687B1 Alcohol acetyl transferase gene and use thereof
08/03/2011	EP1860119B1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
08/03/2011	EP1814998B1 Animal models comprising at least one conditional ko and one conditional ki
08/03/2011	EP1786905B1 Small interfering rna molecules against ribonucleotide reductase and uses thereof
08/03/2011	EP1688488B1 Bispecific antibody substituting for factor viii
08/03/2011	EP1631314B1 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
08/03/2011	EP1575483B1 Attenuated gram negative bacteria
08/03/2011	EP1332210B1 Use of mutagenic dna polymerase for producing random mutations
08/03/2011	EP1317282B1 Vectors for molecule delivery to cd11b expressing cells

1 ... 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 ... 4023